Celcuity's Convertible Note - II Round

Celcuity raised a round of funding on May 19, 2017.

Celcuity is developing diagnostic tests that use a patient's live tumor cells to identify the specific biological driver of their cancer. The company's CELx Signaling Function technology represents a …

Articles about Celcuity's Convertible Note - II Round: